Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $43.60
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective […]
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective […]
